Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus.

Lei GuoJunjie WangHuaiyu DingShaoke MengXiaoyan ZhangHaichen LvLei ZhongJian WuJiaying XuXuchen ZhouRongchong Huang

Published in: Cardiovascular diabetology (2020)

For treatment of CTO, successful CTO-PCI highly reduces the risk of MACE in diabetic patients when compared with medical therapy. However, this does not apply to non-diabetic patients.

Keyphrases

coronary artery disease
healthcare
type diabetes
stem cells
cardiovascular disease
left ventricular
st elevation myocardial infarction
cell therapy
combination therapy
cardiovascular risk factors
transcatheter aortic valve replacement
ejection fraction